ROCHE FARMACUTICA QUMICA LDA
A United Kingdom supplier, with 2 awarded contracts, totalling £2.5m, most recently 11 months ago.
This contract opportunity involves the supply of specific antineoplastic and immunomodulatory medications, including Atezolizumab (1200 MG/20 ML) and a combination of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide. The total value of the contract is approximately €693,707.04. Suppli
This contract involves the procurement of two specific medications: Pertuzumab and Trastuzumab, each in a concentration of 60 mg/ml, provided as a solution for injection. The total value of the contract is approximately €1,794,909.96. The buyer is the Unidade Local de Saúde Santa Maria, E.P.E., and
